M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B

References

• Berzofsky JA, Ahlers JD, Belyakov IM. Strategies for designing and optimizing new generation vaccines. Nat Rev Immunol 2001; 1: 209–219
   PubMed Web of Science ®Google Scholar
• Boury F, Marchais H, Benoit JP, Proust JE. Surface characterization of poly (α-hydroxy acid) microspheres prepared by solvent evaporation/extraction process. Biomaterials 1997; 18: 125–136
   PubMed Web of Science ®Google Scholar
• Brodsky FM, Guagliardi L. The cell biology of antigen processing and presentation. Annu Rev Immunol 1991; 9: 707–744
   PubMed Web of Science ®Google Scholar
• Chen H, Torchilin V, Langer R. Lectin bearing polymerized liposomes as potential oral vaccine carriers. Pharm Res 1996; 13: 1378–1383
   PubMed Web of Science ®Google Scholar
• Clark MA, Jepson MA, Simmons NL, Booth TA, Hirst BH. Differential expression of lectin binding sites defines mouse intestinal M-cells. J Histochem Cytochem 1993; 41: 1679–1687
   PubMed Web of Science ®Google Scholar
• Cleland JL, Jones AJS. Stable formulation of recombinant human growth hormones and interferon gamma for microencapsulation in biodegradable microspheres. Pharm Res 1996; 13: 1464–1475
   PubMed Web of Science ®Google Scholar
• Coombes AGA, Yeh MK, Lavelle EC, Davis SS. The control of protein release from poly (dl-lactide-co-glycolide) microparticles by variation of external aqueous phase surfactant in the water in oil in water method. J Control Release 1998; 52: 311–320
   PubMed Web of Science ®Google Scholar
• De Aizpurua HJ, Russell-Jones GJ. Identification of the classes of the proteins that provide an immune response upon oral feeding. J Exp Med 1998; 167: 440–451
   Google Scholar
• Deres K, Schild H, Wiesmuller K-H, Jung G, Rammensee H-G. In vivo priming of virus specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature (London) 1989; 342: 561–564
   PubMed Web of Science ®Google Scholar
• Elson CO, Ealding W, Lefkowitz J. A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. J Immunol Methods 1984; 67: 101–108
   PubMed Web of Science ®Google Scholar
• Ertl B, Heigl F, Wirth M, Gabor F. Lectin mediated bioadhesion: Preparation, stability and caco-2 binding of wheat germ agglutinin-functionalized poly (d,l-lactic-co-glycolic acid)-microspheres. J Drug Target 2000; 8: 173–184
   PubMed Web of Science ®Google Scholar
• Ezpeleta I, Irache JM, Stainmesse S, Chabenat C, Gueguen J, Orecchioni AM. Preparation of lectin-vicilin nanoparticles conjugate using the carbodiimide technique. Int J Pharm 1996; 142: 227–233
   Web of Science ®Google Scholar
• Florence AT, Hillery A, Hussain N, Jani PU. Factors affecting the oral uptake and translocation of polystyrene nanoparticles: Histological and analytical evidence. J Drug Target 1995; 3: 65–70
   PubMed Web of Science ®Google Scholar
• Foster N, Clark MA, Jepson MA, Hirst BH. Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo. Vaccine 1998; 16: 536–541
   PubMed Web of Science ®Google Scholar
• Gabor F, Stangl M, Wirth M. Lectin mediated bioadhesion: Binding characteristics of plant lectins on the enterocyte like cell lines Caco-2, HT-29 and HCT-8. J Control Release 1995; 55: 131–142
   Google Scholar
• Gupta PN, Mahor S, Rawat A, Khatri K, Goyal A, Vyas SP. Lectin anchored stabilized biodegradable nanoparticles for oral immunization: 1. Development and in vitro evaluation. Int J Pharm 2006; 318: 163–173
   PubMed Web of Science ®Google Scholar
• Gutierro I, Hernandez RM, Igartua M, Gascon AR, Pedraz JL. Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded microspheres. Vaccine 2002; 21: 67–77
   PubMed Web of Science ®Google Scholar
• Honda S, Suzuki S. Common conditions for high performance liquid chromatographic micro determination of aldoses, hexosamines and sialic acid in glycoproteins. Anal Biochem 1984; 142: 167–174
   PubMed Web of Science ®Google Scholar
• Isaka M, Yasuda Y, Mizokami M, Kozuka S, Taniguchi T, Matano K, Maeyama J, Mizuno K, Morokuma K, Ohkuma K, Goto N, Tochikubo K. Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant. Vaccine 2001; 19: 1460–1466
   PubMed Web of Science ®Google Scholar
• Jaganathan KS, Vyas SP. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Vaccine 2006; 24: 4201–4211
   PubMed Web of Science ®Google Scholar
• Jaganathan KS, Singh P, Prabakaran D, Mishra V, Vyas SP. Development of a single-dose stabilized poly (dl-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B. J Pharm Pharmacol 2004; 56: 1243–1250
   PubMed Web of Science ®Google Scholar
• Jepson MA, Clark MA. Studying M cells and their role in infection. Trends Microbiol 1998; 6: 359–365
   PubMed Web of Science ®Google Scholar
• Katz DE, Delorimier AJ, Wolf MK, Hall ER, Cassels FJ, van Hamont JE, Newcomer RL, Davachi MA, Taylor DN, McQueen CE. Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) C56 antigen. Vaccine 2003; 21: 341–346
   PubMed Web of Science ®Google Scholar
• Lavelle EC, Grant G, Pusztai A, fuller U, O'Hagan DT. Identification of plant lectin with mucosal adjuvant activity. Immunology 2001; 102: 77–86
   PubMed Web of Science ®Google Scholar
• Lavelle EC, Grant G, Pfuller U, O'Hagan DT. Immunological implication of the use of plant lectins for drug and vaccine targeting to the gastrointestinal tract. J Drug Target 2004; 12: 89–95
   PubMed Web of Science ®Google Scholar
• Marcotte H, Lavoie MC. Oral microbial ecology and the role of salivary immunoglobulin A. Microbiol Mol Biol Rev 1998; 62: 71–109
   PubMed Web of Science ®Google Scholar
• Montisci MJ, Giovannnuci G, Douchene D, Ponchel G. Covalent coupling of asparagus pea and tomato lectin to poly (lactide) microspheres. Int J Pharm 2001; 215: 153–161
   PubMed Web of Science ®Google Scholar
• Nakane A, Numata A, Minagawa T. Endogenous tumor necrosis factor, interleukin-6, and gamma interferon levels during Listeria monocytogenes infection in mice. Infect Immun 1992; 60: 523–528
   PubMed Web of Science ®Google Scholar
• O' Hagan DT. Microparticles and polymers for the mucosal delivery of vaccines. Adv Drug Deliv Rev 1998; 34: 305–320
   PubMed Web of Science ®Google Scholar
• Perez C, Griebenow K. Improved activity and stability of lysozyme at the water/CH2Cl2 interface: Enzyme unfolding and aggregation and its prevention by phenols. J Pharm Pharmacol 2001; 53: 1217–1226
   PubMed Web of Science ®Google Scholar
• Roth-Watler F, Scholl I, Untersmayr E, Fuchs R, Boltz-Nitulescu G, Weissenbock A, Scheiner O, Gabor F, Jenson-Jarolim E. M-cell targeting with Alenuria auerantia lectin as a novel approach for oral allergen immunotherapy. J Allergy Clin Immunol 2004; 114: 1362–1368
   PubMed Web of Science ®Google Scholar
• Roth-Watler F, Scholl I, Untersmayr E, Ellinger A, Boltz-Nitulescu G, Scheiner O, Gabor F, Jenson-Jarolim E. Mucosal targeting of allergen-loaded microspheres by Alenuria auerantia lectin. Vaccine 2005; 23: 2703–2710
   PubMed Web of Science ®Google Scholar
• Russell-Jones GJ. The potential of receptor mediated endocytosis for oral drug delivery. Adv Drug Deliv Rev 2001; 1: 59–73
   Google Scholar
• Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohal associated with poly (d, l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Rel 2002; 82: 105–114
   PubMed Web of Science ®Google Scholar
• Sansonetti PJ, Phalipon A. M cells as port of entry for enteroinvasive pathogens: Mechanism of interaction, consequences for the disease process. Semin Immunol 1999; 11: 193–203
   PubMed Web of Science ®Google Scholar
• Shenderova A, Burke T, Schwenderman SP. The acidic microclimate in poly (lactide-co-glycolide) microspheres stabilizes camptothecins. Pharm Res 1999; 16: 241–248
   PubMed Web of Science ®Google Scholar
• Shi L, Caulfield MJ, Chern RT, Wilson RA, Sanyal G, Volkin DB. Pharmaceutical and immunological evaluation of single-shot hepatitis B vaccine formulated with PLGA microspheres. J Pharm Sci 2002; 91: 1019–1035
   PubMed Web of Science ®Google Scholar
• Singh M, Li X, McGhee JP, Zamb T, Koff W, Wang CY, O'Hagan DT. Controlled release microparticles as a single dose hepatitis B vaccine: Evaluation of immunogenicity in mice. Vaccine 1997; 15: 475–481
   PubMed Web of Science ®Google Scholar
• Vyas SP, Sihorkar V, Dubey PK. Preparation, characterization and in vitro antimicrobial activity of metronidazole bearing lectinized liposomes for intra-peridontal pocket delivery. Pharmazie 2001a; 56: 554–560
   PubMed Web of Science ®Google Scholar
• Vyas SP, Singh A, Sihorkar V. Ligand–receptor-mediated drug delivery: An emerging paradigm in cellular drug targeting. Crit Rev Ther Drug Carrier Syst 2001b; 18: 1–76
   PubMed Web of Science ®Google Scholar
• Walter F, Scholl I, Untersmayr E, Ellinger A, Boltz-nitulescu G, Scheiner O, Gabor F, Jensen-Jarolim E. Functionalization of allergen loaded microspheres with wheat germ agglutinin for targeting enterocytes. Biochem Biophys Res Comm 2004; 315: 281–287
   PubMed Web of Science ®Google Scholar
• Yeh MK, Liu YT, Chen JL, Chiang CH. Oral immunogenicity of the inactivated Vibrio cholerae whole cell vaccine encapsulated in biodegradable microparticles. J Control Release 2002; 82: 237–247
   PubMed Web of Science ®Google Scholar
• Zhu G, Millery SR, Schwendeman SP. Stabilization of protein encapsulated in injectable poly (lactide-co-glycolide). Nat Biotech 2000; 18: 52–57
   PubMed Web of Science ®Google Scholar